Compare UCTT & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCTT | SDGR |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2004 | 2020 |
| Metric | UCTT | SDGR |
|---|---|---|
| Price | $26.08 | $18.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $32.50 | $26.25 |
| AVG Volume (30 Days) | 511.6K | ★ 800.0K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,110,600,000.00 | $256,951,000.00 |
| Revenue This Year | N/A | $23.69 |
| Revenue Next Year | $5.74 | $20.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.65 | ★ 32.90 |
| 52 Week Low | $16.66 | $15.99 |
| 52 Week High | $40.10 | $28.47 |
| Indicator | UCTT | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 51.45 |
| Support Level | $25.57 | $17.02 |
| Resistance Level | $26.42 | $19.44 |
| Average True Range (ATR) | 1.04 | 0.79 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 45.21 | 52.48 |
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.